Pimavanserin Tartrate
CAS 70693-62-8 7 FDA-DMF suppliersSmall Molecule
Overview
Pimavanserin Tartrate is an atypical antipsychotic that targets the serotonergic system and is used primarily for the treatment of Parkinson's disease psychosis. It functions by selectively antagonizing serotonin receptors and is notable for not influencing dopaminergic receptors.
Therapeutic areas
NeurologyPsychiatry
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.